Home/Pipeline/Lighthouse Pilot Product

Lighthouse Pilot Product

Not Specified

PilotLaunched 2020

Key Facts

Indication
Not Specified
Phase
Pilot
Status
Launched 2020
Company

About Cipherome

Founded in 2015 in Silicon Valley, Cipherome aims to accelerate precision medicine by simplifying complex healthcare data analysis. The company has evolved from a pharmacogenomics focus to offering the COMPASS platform, a comprehensive tool for clinical research, genomic analysis, and AI model training. Cipherome has conducted clinical validation studies with prestigious institutions and is actively commercializing its platform while contributing to healthcare data science education.

View full company profile

Other Not Specified Drugs

DrugCompanyPhase
Inflammation ProgramsArcus BiosciencesNot Specified
Bone Marrow Conditioning ProgramTelix PharmaceuticalsPipeline
AGMB-447Agomab TherapeuticsNot Disclosed
AGMB-101Agomab TherapeuticsNot Disclosed
TRIFERTY-ATM®Laboratorio Reig JofreApproved/Commercial
AGEN1571 (anti-ILT2)AgenusNot specified
AGEN1777AgenusNot specified
AGEN1721AgenusNot specified
INCAGN1876 (GITR Agonist)AgenusNot specified
INCAGN1949 (OX40 Agonist)AgenusNot specified
AGEN1327 (anti-TIGIT)AgenusNot specified
AGEN2373 (CD137 Agonist)AgenusNot specified